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In Gram-positive bacteria, tyrosine kinases are split into two proteins, the cytoplasmic 17 
tyrosine kinase and a transmembrane adaptor protein. In Streptococcus pneumoniae this 18 
transmembrane adaptor is CpsC, with the C-terminus of CpsC critical for interaction and 19 
subsequent tyrosine kinase activity of CpsD. Topology predictions suggest CpsC has two 20 
transmembrane domains, with the N and C-termini present in the cytoplasm. In order to 21 
investigate CpsC topology, we used a chromosomal HA-tagged Cps2C protein in D39. 22 
Incubation of both protoplasts and membranes with the CP-B resulted in complete 23 
degradation of HA-Cps2C in all cases, indicating that the C-terminus of Cps2C was likely 24 
extra-cytoplasmic, and hence the protein’s topology was not as predicted. Similar results 25 
were seen with membranes from TIGR4, indicating Cps4C also showed similar topology. A 26 
chromosomally encoded fusion of HA-Cps2C and Cps2D was not degraded by CP-B, 27 
suggesting that the fusion fixed the C-terminus within the cytoplasm. However, capsule 28 
synthesis was unaltered by this fusion. Detection of the CpsC C-terminus by flow cytometry 29 
indicated that it was extra-cytoplasmic in approximately 30% of cells. Interestingly, a mutant 30 
in the protein tyrosine phosphatase CpsB had a significantly greater proportion of positive 31 
cells, although this affect was independent of its phosphatase activity. Our data indicate that 32 
CpsC possesses a varied topology, with the C-terminus flipping across the cytoplasmic 33 
membrane where it interacts with CpsD in order to regulate tyrosine kinase activity. 34 
 35 







The critical importance of bacterial tyrosine phosphorylation to the basic physiology and 39 
virulence of a wide range of pathogens is becoming increasingly more recognized (1). This 40 
has led to investigation of bacterial protein tyrosine phosphatases and tyrosine kinases (BY-41 
kinases) as novel targets for the development of antimicrobials (2, 3). Streptococcus 42 
pneumoniae is one such human pathogen for which tyrosine phosphorylation is critical. In the 43 
pneumococcus, tyrosine phosphorylation plays an important role in regulation of the 44 
biosynthesis of the polysaccharide capsule. The capsule is considered the major virulence 45 
factor of the pneumococcus, through its ability to act as an anti-phagocytic factor (4), and 46 
indeed all isolates causing invasive disease are encapsulated. 47 
 48 
In recent times, we have investigated the role of a tyrosine phosphoregulatory system in the 49 
regulation of the biosynthesis of the polysaccharide capsule.  The three genes responsible for 50 
this system are co-transcribed at the 5’ end of the capsule locus, with all being essential for 51 
the complete encapsulation of the pneumococcus (5-8). These three genes are responsible for 52 
encoding a protein tyrosine phosphatase (CpsB) (6) which acts to dephosphorylate an auto-53 
phosphorylating bacterial tyrosine kinase CpsD (BY-kinase), along with the polysaccharide 54 
co-polymerase protein (PCP) CpsC (7). While in Gram-negative bacteria BY-kinases are 55 
present as one single protein, in Gram-positive bacteria they are comprised of two separate 56 
co-transcribed proteins which are required for kinase activity (7, 9). In the pneumococcus, 57 
this adaptor protein is CpsC. CpsD forms the active tyrosine kinase, possessing the Walker A 58 
and B motifs, as well as the tyrosines present at its C-terminus which are trans-59 
autophosphorylated by another CpsD monomer (9). However, CpsC is required for this 60 





studies of the Staphylococcus aureus homologs (9), and thus absence of CpsC results in a 62 
lack of detectable CpsD auto-phosphorylation (7, 10).  63 
 64 
CpsC is a member of the 2b sub-family of PCPs (11). In Gram-negative bacteria, PCP 65 
proteins are associated with regulating O-antigen chain length during O-antigen 66 
polymerization and synthesis of type 1 capsules and exopolysaccharides (8, 11). Previous 67 
work undertaken in our laboratory has suggested CpsC is critical for the attachment of 68 
capsule to the cell wall (12), while a number of amino acid substitutions in this large extra-69 
cytoplasmic loop significantly reduced phosphorylation of the BY-kinase CpsD (13). This 70 
suggests that there is a signal which can be transmitted across the cytoplasmic membrane to 71 
or from this extracellular loop which affects CpsD BY-kinase activity. However, the nature 72 
of this signal and its transmission is still unknown. 73 
 74 
In this study, we investigated the topology of CpsC to provide insight into the mechanism for 75 
CpsC activation of CpsD. Unexpectedly, using a variety of methods, and in two different 76 
strains, we discovered that the C-terminus of CpsC has varied topology, with it being both 77 
intra- and extra-cytoplasmic. We suggest that this novel CpsC topology may be critical in its 78 
ability to regulate CpsD tyrosine kinase activity, and thus regulate encapsulation of this major 79 
human pathogen. 80 





Materials and Methods 82 
Growth Media and Growth conditions 83 
S. pneumoniae D39, and TIGR4 were grown in Todd-Hewitt broth with 1% Bacto yeast 84 
extract (THY), or on blood Agar. Broth cultures were grown at 37 °C without agitation. 85 
Escherichia coli strains were grown in Luria-Bertani broth (10g/L Tryptone, 5 g/L yeast 86 
extract, 5 g/L NaCl) broth or agar, with transformation carried out using CaCl2-treated cells. 87 
Antibiotics used were as follows: Erythromycin (Ery): S. pneumoniae 0.2 µg/ml; Ampicillin 88 
(Amp) 100 µg/ml. 89 
 90 
DNA Methods 91 
E. coli K-12 DH5α was used for all cloning experiments. DNA manipulation, PCR, 92 
transformation and electroporation was performed as previously described 93 
(14). Oligonucleotide sequences are available on request. 94 
  95 
  96 
 97 
Production of StrepTagII-Cps4CD  98 
A fusion protein comprising the last 29 aa’s of Cps4C (the predicted cytoplasmic region) with 99 
the entire Cps4D protein was constructed by overlap extension PCR. First, the coding 100 
sequence for the CpsC C-terminus without its stop codon was amplified using AS1/AS2, and 101 
the coding sequence for the CpsD protein was amplified with AS3/AS4 using DNA from 102 
TIGR4 S. pneumoniae as template. A second round of PCR with AS1/AS4 stitched these 103 
products together. This PCR was then digested with KpnI and SacI, restriction sites for which 104 
were included in primers AS1/AS4. This digested PCR product was then ligated into likewise 105 





transformed into DH5α, screened by PCR, with the correct plasmid confirmed by sequencing 107 
(pTRIEX6-Cps4CD). pTRIEX6-Cps4CD was isolated and then transformed into Lemo21 108 
(DE3) (15) for protein over-expression, yielding strain AS35.  109 
For over-expression, strains were grown at 37 °C for 16 h in LB, subcultured 1/20 into fresh 110 
broth and grown for another 2 hr to an OD600 of ≈ 0.5. Strep-TagII-Cps4CD expression was 111 
then induced by addition of 1 mM IPTG for further 2 h. The bacteria were pelleted, and the 112 
cells disrupted using a Constant Systems cell disruptor. The soluble recombinant StrepTagII-113 
Cps4CD was then purified using an AKTA prime plus (GE Life Sciences) with a StrepTrap 114 
(GE Healthcare Life Sciences) as per manufacturer’s instructions, resulting in the purification 115 
of approximately 2 mg/ml CpsCD. Protein was then supplied to IMVS, Veterinary Services, 116 
Gilles Plain SA, Australia where polyclonal rabbit serum was produced, designated αCpsCD.  117 
 118 
Construction of strain D39EHA:CpsC-L11-CpsD and D39CpsBH136A 119 
A strain was constructed which comprised Cps2C fused to Cps2D with a linker (L11) based 120 
on a previous study using a different pneumococcal serotype (16). The initial rounds of PCR 121 
amplified cps2C with linker (Cps5’ + AS 169) and cps2D with linker AS168 + AS159, using 122 
D39EHA:Cps2C chromosomal DNA. These products were then combined in a second round 123 
of PCR with oligonucleotides Cps5’ + AS159. Transformation and selection were performed 124 
as described previously (17), and transformed colonies were screened by PCR and DNA 125 
sequencing. 126 
In order to construct a point mutation in CpsB which inactivated its phosphatase activity, we 127 
constructed D39CpsBH136A based on a recent study(18). Originally, a strain (D39cpsJANUS ) 128 
was constructed with the janus cassette (19) inserted in place of cpsB, cpsC and cpsD. In 129 
order to do this, first the janus cassette was amplified with oligonucleuotides AS113 and 130 





AS159) of cpsBCD.  The three PCRs were then combined in a second round of PCR with 132 
Cps5’ and AS 159. This was then transformed into streptomycin resistant D39. 133 
Oligonucleotides AS262 + AS159, and AS263 + Cps5’ were then used to amplify cps2B 134 
from D39 S. pneumoniae encoding the relevant change. The PCRs were combined by a 135 
second round of PCR using AS159 + Cps5’ and then this PCR was then transformed into 136 
D39cpsJANUS. The relevant mutation was confirmed by DNA sequencing. 137 
 138 
Western Immunoblotting 139 
Insoluble fractions, protoplasts, and whole cell lysates were separated on 12% SDS-PAGE 140 
and transferred to Nitrobind (GE Water and Process technologies). In order to investigate the 141 
presence of smaller digested products, insoluble fractions were separated on 16.5% Mini-142 
PROTEAN Tris Tricine Gels (Biorad) according to the manufacturer’s instruction, prior to 143 
Western immunoblotting. Membranes were probed with primary antibody overnight (αHA 144 
(Sigma Aldrich; #H3663) 1/2500, or αCpsCD (1/1000), αPY (4G10, Bio X Cell; #BE0194) 145 
and after washing, incubated with either goat anti-rabbit or goat anti-mouse secondary 146 
antibodies (Biomediq DPC) for 2 h. Detection was performed with chemiluminescence 147 
blotting substrate (Sigma Aldrich) as per manufacturer’s instructions. Benchmark prestained 148 
molecular weight markers (Life Technologies) were used as molecular size markers. 149 
Stripping of western immunoblots was performed by incubation with Restore PLUS Western 150 
Blot Stripping buffer (Thermo Scientific). 151 
 152 
Protoplast formation 153 
Pneumococci were grown to OD600 = 0.5 in THY at 37 °C, washed twice in 300 µL 154 
phosphate buffered saline (PBS), followed a single wash in 250 µL of 0.05 mM EDTA, pH 155 





pH 6.8, 0.1 mM MgCl2, 10 U/mL mutanolysin (Sigma Aldrich), 40 % (w/v) sucrose) before 157 
incubation for 3 h at 37 ˚C. Protoplasts were washed twice in 200 µL 40 % (w/v) sucrose 158 
PBS solution, with confirmation of protoplast formation by phase contrast microscopy. 159 
 160 
Isolation of membrane containing fractions 161 
S. pneumoniae cultures were harvested at 17000 × g for 30 mins. Pellets were resuspended in 162 
10 mL resuspension buffer (RB) (100 mM Tris-HCl pH 7.4, 200 mM NaCl, 20% glycerol) 163 
with 100 µL 100x Protease Arrest (Gbiosciences) and 5 mM  EDTA. Bacterial suspensions 164 
were lysed at > 1000 PSI via a French pressure cell. Cell debris was removed at 20,000 × g 165 
for 50 mins. Pellets containing bacterial membranes were isolated from the supernatant by 166 
ultra-centrifugation at 150,000 × g for 1 h. Pellets were then washed 3 × in 50 mL RB before 167 
resuspension in ~100 µL RB, after which total membrane was quantified using BCA Protein 168 
Assay (Pierce). 169 
 170 
Carboxypeptidase B accessibilty assays 171 
Carboxypeptidase B (CP-B) (Sigma Aldrich) analysis was conducted according to 172 
manufacturer instructions. In brief, CP-B digestion was conducted in a 20 µL of 25 mM Tris-173 
HCl pH 7.65, 200 mM NaCl at 25 °C for 1 h. 1 mg.mL-1 of total bacterial membrane protein 174 
or 10 µL of protoplasts were used in all assays. In order to identify degradation products, the 175 
reaction size was increased to 1 ml, and following CP-B digestion, membranes were isolated 176 
by ultra-centrifugation at 150,000 × g for 1hr and subsequently analysed by SDS-PAGE and  177 
Western immunobloting. Protoplast CP-B analysis occurred in 40% (w/v) sucrose to prevent 178 
cell lysis. CP-B reactions were stopped after 1 h by the addition of 2 µL of a 10x Protease 179 
Arrest, 50 mM EDTA solution. Samples were then analysed by Western immunoblotting. 180 





Cps2D membranes by solubilization in 0.5 % (w/v) DDM for 1 hr at 25 °C. The remaining 182 
insoluble membrane and protein was then removed by ultra-centrifugation at 150,000 × g for 183 
1hr, before incubation of the solubilized protein with CP-B. 184 
 185 
Flow cytometric analysis 186 
Flow cytometric analysis was carried out on bacterial protoplasts as prepared above. 187 
Protoplasts were fixed in PBS with 25 % (w/v) NaCl, 3.7 % (v/v) formaldehyde for 20 188 
minutes and washed in PBS with 40 % (w/v) sucrose. The cells were blocked in PBS with 40 189 
%  (w/v) sucrose, 10 % (v/v) fetal calf serum, and then with primary rabbit α-CpsCD 190 
antibody (1/50) for 3 h. Following 3 washes in PBS with 40 % (w/v) sucrose, protoplasts 191 
were incubated with secondary Alexa Fluor 488 nm donkey-α-rabbit (Life Technologies) 192 
antibody for 1 h. Following 3 washes in PBS with 40 % (w/v) sucrose, flow cytometric 193 
analysis of the labelled pneumococcal protoplasts (≥10,000 events) was then performed on 194 
the bacterial protoplasts using a BD FACSCanto (Becton Dickinson Biosciences) cell 195 
analyzer, with excitation laser at 488 nm, and emission captured using the FITC 530/30 filter. 196 
Baseline fluorescence was calibrated using secondary antibody only. Analysis was performed 197 
by FlowJo. Cells were calculated as positive in relation to a negative control which had only 198 
the secondary antibody.  199 
 200 
Uronic Acid Assay 201 
The quantitative uronic acid assay was undertaken essentially as described previously (2, 12). 202 
Levels were related back to a standard curve of D-glucuronic acid (Sigma).  203 





Results  205 
Topology predictions of CpsC 206 
While topology investigations of PCP proteins have been undertaken, the PCP 2b subfamily 207 
has so far been neglected.  The predicted topology of Cps2C is shown in Figure 1. To predict 208 
this topology we have analysed this protein with the following topology programs, 209 
SPOCTOPUS (20), TOPSCONS (21), TMpred(22), and Philius (23) all with similar results.  210 
Cps2C was predicted to have two transmembrane domains with the N and C-terminus in the 211 
cytoplasm. The large extra-cytoplasmic loop is thought to contain a series of alternating α-212 
helices and β-strands (24). We were thus interested if these predictions were accurate and set 213 
out to investigate the topology of CpsC. 214 
 215 
CP-B cleaves Cps2C and Cps4C in pneumococcal membranes  216 
We initially investigated the topology of Cps2C using CP-B accessibility assays. CP-B is a 217 
C-terminal peptidase with a propensity for basic amino acids, of which there are a substantial 218 
number at the C-terminal end of CpsC. Previously, this has been used successfully to 219 
investigate the topology of related PCP proteins (25). CP-B was expected to cleave Cps2C 220 
until it met the cell membrane. Using this method, we therefore expected we would be able to 221 
determine the orientation and size of the predicted C-terminal cytoplasmic region. In previous 222 
work, we constructed a strain which expressed Cps2C fused to a HA tag at its N-terminus 223 
(13). We reasoned this would allow identification of cleavage products, as αHA recognizes 224 
its epitope at the N-terminus of the protein.  225 
 226 
We undertook CP-B cleavage assays using membrane fractions of D39EHA:Cps2C. 227 
Following incubation with the protease, the fractions were separated on SDS-PAGE, and 228 





HA-Cps2C. Using this method we saw significant degradation of Cps2C by CP-B (Figure 230 
2A & 2B). However, there was no evidence of smaller degradation products. The predicted 231 
transmembrane region should have stopped CP-B cleavage, resulting in degradation products 232 
of significant size, and enabling estimation of the size of the cytoplasmic C-terminus. As the 233 
predicted cytoplasmically located C- terminus of Cps2C has a predicted molecular weight of 234 
4.6 kDa (Expasy), we would have expected to identify a protein that was approximately 24 235 
kDa. In order to investigate if CP-B was simply degrading all proteins, we separated the 236 
proteins from CP-B treated membranes by SDS-PAGE and stained the proteins with 237 
Coomassie Brilliant Blue (Figure 2C). Few proteins showed any obvious degradation, 238 
suggesting that the CP-B cleavage of HA-Cps2C detected was not due to a non-specific 239 
degradation of all protein. Thus, this led to the hypothesis that the topology of Cps2C was not 240 
as predicted in Figure 1.  241 
In an effort to detect smaller degradation products, we increased the reaction size and 242 
optimised the Western blotting procedure as described in Materials and Methods. A band of 243 
approximately 9 kDa was evident when we digested with CP-B (Figure 2D), with its intensity 244 
increasing with increasing CP-B concentration. Interestingly, this correlated with the 245 
approximate size of the N-terminus along with its predicted trans-membrane domain (8.1 246 
kDa; Expasy). This suggested that CpsC possesses one and not two transmembrane regions.  247 
In order to investigate whether CP-B degradationoccurred across serotypes, we investigated 248 
cleavage of Cps4C from TIGR4. As Cps4C and Cps2C share significant homology (78% 249 
Identity), they are predicted to have similar topologies. As this strain did not possess a HA-250 
Cps4C, initially, αCpsCD, produced as described in Materials and Methods was used to 251 
probe E. coli expressed StrepTagII-Cps4C in a Western immunoblot, and a band of the 252 
expected size was detected indicating that this antibody recognized S. pneumoniae Cps4C 253 





antibody) and Cps4C is epitopes corresponding to the C terminal 29 aa of Cps4C. Thus, we 255 
used this antibody to probe CP-B degradation of Cps4C in S. pneumoniae TIGR4 256 
membranes. Insoluble membrane fractions were used such that the antibody could not 257 
recognize Cps4D, which is a soluble cytoplasmic protein, and has been shown previously to 258 
not be present in membrane fractions (7). TIGR4 membrane fractions were incubated with 259 
CP-B, and subsequently analyzed for cleavage by Western immunoblotting, probing with 260 
αCpsCD. With S. pneumoniae TIGR4 membranes, significant degradation of Cps4C was 261 
detected (Figure 3B & 3C), with almost complete degradation seen with 100 µg/ml CP-B. 262 
Thus, this suggested that these proteins did indeed share similar topology.  263 
 264 
Cps2C is cleaved in D39EHA:Cps2C pneumococcal protoplasts 265 
In order to investigate this further we performed CP-B cleavage on D39EHA:Cps2C 266 
protoplasts. Cleavage would only be expected to occur if the C-terminus was extra-267 
cytoplasmic, as the protease should not enter the cell. Interestingly, significant cleavage of 268 
Cps2C was also evident here (Figure 4A and 4D). As a control to ensure CP-B did not enter 269 
the cell, we stripped the Western immunoblot and re-probed with anti-CpsCD which while it 270 
recognizes CpsC when used at high concentrations, predominantly recognizes CpsD (as seen 271 
by the size difference between the bands in Figure 4A and 4B). This showed CpsD was not 272 
cleaved (Figure 4B). Additionally, this also showed that there were not a significant 273 
proportion of cells lysing during the protoplast process which would account for the 274 
degradation of Cps2C. However, when lysed D39 protoplasts were incubated with CP-B, 275 
significant degradation of CpsD was evident (Figure 4C). Thus, this data suggested CP-B 276 
could not traverse the protoplast cell membrane and enter the cytoplasm.  This suggested that 277 
the C-terminus of Cps2C was exposed to the external environment.  278 





Henriques et al. (2011) (16) recently showed that fusion of CpsC and CpsD on the 280 
chromosome resulted in a strain which was still encapsulated and regained tyrosine kinase 281 
activity. We postulated that fusion of CpsC and CpsD would change the topology and 282 
localization of CpsC, resulting in its C-terminus being fixed within the cytoplasm. Thus, we 283 
constructed a fusion on the pneumococcal chromosome linking the two proteins via a linker 284 
as previously described by Henriques et al (2011). This strain, D39EHA:Cps2C-L11-Cps2D 285 
produced capsule to a similar level compared to the wildtype D39EHA:Cps2C strain (Figure 286 
5A), which confirms previous findings (16). Furthermore, the strain produced an 287 
approximately 52kdA protein (corresponding to the size of CpsC + CpsD + L11 + HA tag) 288 
which reacted both with α-HA, α-CpsCD and also intensely with α-PY (4G10) indicative that 289 
it was producing an active tyrosine kinase protein, able to auto-phosphorylate on tyrosines at 290 
its C-terminus (Figure 5B). 291 
 292 
In order to investigate CpsC topology in this strain, we incubated both protoplasts and 293 
insoluble protein fractions with CP-B.  CP-B was unable to cleave Cps2C-L11-Cps2D when 294 
it was incubated with either insoluble membrane fractions or protoplasts of D39EHA:Cps2C-295 
L11-Cps2D (Figure 5C, 5D, 5E & 5F). We confirmed CP-B was able to cleave this Cps2C-296 
L11-CpsD fusion by solubilizing the membrane protein out of the insoluble fraction and then 297 
performing the CP-B cleavage (Figure 5G). Thus, these results suggested that fusion of 298 
CpsC to CpsD altered the topology of CpsC, although did not alter its activity in promoting 299 
capsule biosynthesis. 300 
 301 
Flow Cytometry Analysis 302 
As described above, α-CpsCD recognizes both the C-terminal region of Cps4C, and Cps4D.  303 





insoluble membrane fractions of D39EHA:Cps2C and D39EHA:CpsCD202∆, a strain in which 305 
the 28 C-terminal amino acids are deleted (13). As D39EHA:CpsCD202∆ expresses 306 
substantially less CpsC than D39EHA:Cps2C, we controlled for this by performing a 307 
simultaneous Western immunoblot with αHA. While α-CpsCD recognized Cps2C in 308 
D39EHA:Cps2C, no corresponding band was detected in D39EHA:CpsCD202∆ (Figure 6). As 309 
this assay was performed with denatured protein, it would be highly unlikely that the 310 
antibody is not recognizing CpsC in D39EHA:CpsCD202∆ due to the mutation affecting the 311 
overall folding of the protein. Thus, this showed that α-CpsCD specifically recognizes the C-312 
terminus of Cps2C. Therefore, we decided to use this antibody in flow cytometry in order to 313 
provide additional evidence that the C-terminus of CpsC was exposed to the environment. 314 
 315 
Initially flow cytometry with αCpsCD was undertaken on whole cell pneumococci, however, 316 
no signal was detected (data not shown). This was not surprising as the capsular 317 
polysaccharide present on the outside of the cell likely shields the C-terminus of Cps2C. 318 
Therefore, we made protoplasts and undertook the flow cytometric analysis as described in 319 
Materials and Methods. D39 wt protoplasts reacted well, with approximately 30% of cells 320 
being positive (Figure 7A, 7B). Conversely, D39cpsBCD∆ had only a very small proportion 321 
of background positive cells (3.3%), which correlated with its lack of Cps2C (Figure 7B). 322 
While D39cpsD∆ protoplasts had a significant reduction in positive cells compared to the wt 323 
(9.5%), this was still greater than that detected for D39cpsBCD∆ protoplasts. Interestingly, 324 
D39cpsB∆ protoplasts showed a significant increase in positive cells. While the lower level 325 
of positive D39cpsD∆ protoplasts could be attributed to a lower level of CpsC as evidenced 326 
by Western immunoblot of insoluble membrane fractions (Figure 7D), D39cpsB produced 327 
similar levels of CpsC to the wt, thus not explaining the increased exposure of the C-terminus 328 





phosphatase activity of CpsB, we constructed a mutant in CpsB (D39CpsBH136A) lacking 330 
tyrosine phosphatase activity(18). Interestingly, this mutation did not have any significant 331 
effect on CpsC exposure, suggesting that CpsB role in CpsC topology was independent of its 332 
phosphatase activity. TIGR4 protoplasts showed higher Cps4C exposure compared to D39 333 
protoplasts (Cps2C) although this did not reach statistical significance (Figure 7B). 334 
 335 
We also investigated the surface exposure of CpsC in D39EHA:Cps2C-L11-Cps2D. 336 
D39EHA:Cps2C-L11-Cps2D had only 4% positive cells, significantly less than its 337 
corresponding wt (D39EHA:Cps2C) and only slightly more than the background 3.3 % 338 
positive cells seen in D39cpsBCD∆ (Figure 7C). This provided further strength to the 339 
observation from the CP-B assays, that the fusion of the proteins results in a protein with 340 




CpsC is a major virulence factor of the pneumococcus, crucial via its role in the regulation of 345 
the biosynthesis of capsular polysaccharide. For this reason, we set out to investigate its 346 
topology, and possible mechanisms it may possess to regulate CpsD BY-kinase activity. Two 347 
complementary methods, CP-B accessibility assays and flow cytometry, provided evidence  348 
that CpsC topology was not as originally thought, but that the C-terminus of the protein could 349 
at least at times be found in an extracellular location. We showed that this phenomenon 350 
occurs across pneumococcal strains, as when we performed CP-B accessibility assays with 351 
insoluble membrane fractions from TIGR4, cleavage was also detected, with almost complete 352 
cleavage at 100 µg/ml. Flow cytometric analysis also detected significant exposure of the C-353 





suggesting that Cps2C and Cps4C likely exhibit similar topologies. The slight difference may 355 
be due to the fact that Cps2C and Cps4C belong to two different sequence clans (26), and 356 
indicating that the C-terminus of Cps4C may be more extracellularly located than Cps2C.  357 
 358 
In order to further investigate this finding, we constructed a strain in which Cps2C was fused 359 
to Cps2D via a linker (D39EHA:Cps2C-L11-Cps2D). We hypothesized that this fusion 360 
would result in a strain that produces CpsC with its C-terminal region fixed in the cytoplasm, 361 
resulting in an altered topology compared to the wt. Indeed, both CP-B accessibility assays 362 
(Figure 5) and flow cytometry (Figure 7), suggested that this was the case.  363 
We know that it is critically important that the C-terminus of CpsC interacts with CpsD in 364 
order for the BY-kinase to gain functionality (9, 27). For this reason, the C-terminus of CpsC 365 
must at least at times be cytoplasmically located. Thus, we hypothesize that the C-terminus of 366 
CpsC possesses multiple topologies, at times with the C-termini located within the cytoplasm, 367 
at other times extracytoplasmically (Figure 1B). We cannot exclude both A and B being 368 
present, and that rapid flipping across the membrane occurs. Examples of a variety of 369 
membrane proteins across a wide range of genera which possess multiple topologies can be 370 
found in the literature (28, 29), and therefore such a finding is not necessarily surprising. It is 371 
additionally interesting to speculate that this is a novel method to regulate BY-kinase CpsD 372 
activity, and that such a mechanism may be conserved across the majority of Gram-positive 373 
bacteria, which possess BY-kinases which are split into two, such as seen in the 374 
pneumococcus. 375 
Fixing of the CpsC C-terminus into the cytoplasm of S. pneumoniae by fusion of CpsC with 376 
CpsD did not affect capsule regulation, as has previously been reported (16). This is not 377 
particularly surprising, as though we still do not know the detailed mechanism of capsule 378 





phosphorylated and non-phosphorylated form of the BY-kinase is critical (27). In this fusion 380 
strain, switching between phosphorylated and non-phosphorylated CpsD would still occur, as 381 
the cognate PTP CpsB acts on the kinase. However, a mutant in the PTP CpsB (D39cpsB∆) 382 
showed a significant increase in surface exposed CpsC C-terminus, even though CpsC 383 
expression levels were similar to wt. While we initially thought that this may have been due 384 
to a loss of phosphatase activity, a mutant which still possesses CpsB but does not have 385 
phosphatase activity did not alter CpsC exposure. Thus, this suggests that the structural 386 
element of CpsB itself is responsible for this effect. Interestingly, a recent study has 387 
suggested that CpsB affects capsule regulation via a mechanism independent of its tyrosine 388 
phosphatase activity (18). Further investigation is required to investigate whether CpsB and 389 
CpsC specifically interact, and whether this may alter CpsC exposure.   390 
It is also important to consider what affects this difference in topology may have on the 3D 391 
structure of the protein. While no structure of CpsC has been reported to date, structures of 392 
other members of the PCP family have been completed (30). In particular PCP proteins have 393 
been shown to form higher order oligomeric structures (FepE – 9, WzzE – 8(30), CapAB - 394 
8(27)). Thus, CpsC likely also forms higher oligomers, and change in CpsC topology would 395 
likely have significant effects on oligomerization, resulting in functional effects. We are 396 
currently working towards a greater structural understanding of CpsC. 397 
This study for the first time has described the variable topology of the C-terminus of the PCP 398 
and BY-kinase adaptor protein CpsC. The switch between these states is likely critical for the 399 
regulation of the activity of the BY-kinase CpsD and subsequent regulation of capsule 400 
biosynthesis. With capsule the major virulence factor of the pneumococcus, a greater 401 
understanding of its regulation is critical such that we can identify new methods to combat 402 
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Figures Legends 505 
Figure 1. Topology of CpsC. (A) Predicted topology of CpsC consisting of two 506 
transmembrane domain and one large extracytoplasmic domain, with the N and C-Termini in 507 
the cytoplasm as determined by various topology prediction programs detailed in the text. 508 
CM represents Cell Membrane (B) Novel topology of CpsC that we predicted based on the 509 
results obtained in this study with C-terminus in extra-cytoplasmic location. It is likely that 510 
topology flips between A and B. 511 
 512 
Figure 2. HA-Cps2C in D39EHA:Cps2C is cleaved by CP-B. 513 
(A) Insoluble membrane fractions from S. pneumoniae D39EHA:Cps2C were isolated and 514 
incubated with indicated concentration of CP-B as described in Materials and Methods. 515 
Western immunoblotting using α-HA was used to investigate effect of the protease. A 516 
representative immunoblot is shown. (B) Densitometric analysis for each concentration as 517 
determined by Image J (N ≥ 3; Mean ± standard error). At 50 and 100 µg/ ml of CP-B 518 
significant cleavage of Cps2C was seen (*** - p < 0.001 and **- p < 0.01; 2-tailed unpaired t 519 
test). No degradation products were detectable. (C) Same samples as above were separated on 520 
SDS-PAGE and stained with Coomassie Brilliant blue. Protein size is shown in kDa. Arrow 521 
indicates the presence of CP-B. (D) In order to identify degradation products, sample 522 
concentration was increased by approximately 10 fold and CP-B digestions were separated on 523 
16.5 % Tris-tricine gels prior to Western immunoblotting. A degradation product of 524 
approximately 9 kDa was identified.  525 
 526 
Figure 3. Cps4C in TIGR4 is cleaved by CP-B. (A) Whole cell lysate from E. coli 527 
Lemo(21) DE3 containing StrepTagII-Cps4C produced a band correlating to the size of CpsC 528 





from S. pneumoniae TIGR4 were isolated and incubated with indicated concentration of CP-530 
B as described in Materials and Methods. Western immunoblotting using α-CpsCD was used 531 
to investigate the protease’s effect. A representative immunoblot is shown. (C) Densitometric 532 
analysis as determined by Image J (N = 2; Mean ± standard error). 100 µg/ ml of CP-B 533 
resulted in almost complete cleavage of Cps4C (** - p < 0.01; 2-tailed unpaired t test). No 534 
degradation products were detectable. 535 
 536 
Figure 4. HA-Cps2C is cleaved by CP-B in protoplasts. 537 
Protoplasts of D39EHA:Cps2C were produced as described in Methods, and then incubated 538 
with CP-B. Protease degradation was detected by Western immunoblotting probing with 539 
either (A) αHA to detect degradation of HA:Cps2C or (B) αCpsCD to detect degradation of 540 
Cps2D. No degradation of CpsD was detected. (C) Lysed protoplasts of D39EHA:Cps2C 541 
were incubated with 100 µg/ ml CP-B and degradation of Cps2D monitored by Western 542 
immunoblotting probing with αCpsCD. Almost complete Cps2D degradation was evident. 543 
(D) Densitometric analysis of degradation of Cps2C in protoplasts by Image J (N = 3). 544 
Significant degradation was seen at 50 and 100 µg/ ml of CP-B (* - p < 0.05 and **** -p < 545 
0.0001; 2-tailed unpaired t test). 546 
 547 
Figure 5. HA:Cps2C-L11-Cps2D is not cleaved by CP-B. 548 
(A) Capsule was prepared from equal numbers of D39EHA:Cps2C (1) and 549 
D39EHA:Cps2C-L11-Cps2D (2) of bacterial cells, and capsule level determined as described 550 
in Materials and Methods.  (B) Whole cell lysates from cells were separated on SDS-PAGE 551 
and Western immunoblotting undertaken with αHA, αCpsCD and αPY. Insoluble membrane 552 
fractions (C) or protoplasts (D) of D39EHA:Cps2C-L11-Cps2D were incubated with CP-B as 553 





probing with αHA. Densitometric analysis using Image J (N ≥ 2; Mean ± standard error), 555 
showed that no cleavage occurred (E,F). (G) Solubilized Cps2C-L11-Cps2D from D39 was 556 
incubated 100 µg/ml CP-B, and cleavage detected by Western immunoblotting probing with 557 
αHA. 558 
 559 
Figure 6. αCpsCD specifically recognises the C-termini of Cps2C. Approximately 600µg 560 
of D39EHA:CpsCD202∆ (lane A) and 140µg of D39EHA:Cps2C (lane B) of insoluble fractions 561 
were subjected to Western Immunoblotting with either αCpsCD or αHA. While both reacted 562 
with HA, only D39EHA:Cps2C reacted with αCpsCD reacted, showing that the antibody 563 
only recognises the C-terminus of Cps2C. 564 
 565 
Figure 7. Flow cytometric analysis of the exposed C-terminus of CpsC. Flow cytometry 566 
of protoplasts from designated strains were investigated as described in Materials and 567 
Methods. (A) Representative plot showing D39 (light blue), D39 + no αCpsCD (orange). 568 
Positive cell population is indicated (B) CpsC-C terminal positive cells were determined as 569 
relative to no αCpsCD control. D39cpsBCD∆ and D39cpsD∆ were significantly less positive 570 
than D39 protoplasts. However, D39cpsD∆ produced significantly more positive cells than 571 
D39cpsBCD∆. D39cpsB∆ displayed enhanced CpsC C-terminus exposure, while a tyrosine 572 
phosphatase deficient mutant (D39CpsBH136A) showed no difference. (C) Additionally, 573 
D39EHA:Cps2C showed significantly greater positive stained cells than D39EHA:Cps2C-574 
L11-Cps2D. (* - p < 0.05; ** - p < 0.01; *** - p < 0.001; Student’s 2 tailed t-test). All results 575 
represent ≥ 3 replicates (except D39CpsBH136A; n = 2) and display Mean ± SE. (D) 10 µg of 576 
insoluble membrane fractions of D39, D39cpsD∆ and D39cpsB∆ were analyzed for CpsC 577 
expression by Western immunoblotting with αCpsCD. D39cpsB∆ had similar levels of CpsC 578 
compared to the wt, while D39cpsD∆ showed decreased expression. 579 







